IPC The Hospitalist
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), IPC The Hospitalist met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue improved significantly and GAAP earnings per share increased significantly.
Gross margins dropped, operating margins shrank, net margins increased.
IPC The Hospitalist reported revenue of $117.9 million. The 11 analysts polled by S&P Capital IQ expected revenue of $116.9 million on the same basis. GAAP reported sales were 21% higher than the prior-year quarter's $97.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.51. The 11 earnings estimates compiled by S&P Capital IQ forecast $0.46 per share. GAAP EPS of $0.51 for Q4 were 21% higher than the prior-year quarter's $0.42 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 26.9%, 230 basis points worse than the prior-year quarter. Operating margin was 10.1%, 180 basis points worse than the prior-year quarter. Net margin was 7.3%, 10 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $127.9 million. On the bottom line, the average EPS estimate is $0.50.
Next year's average estimate for revenue is $516.7 million. The average EPS estimate is $1.99.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 73 members out of 77 rating the stock outperform, and four members rating it underperform. Among 17 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 17 give IPC The Hospitalist a green thumbs-up.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on IPC The Hospitalist is hold, with an average price target of $47.22.
If you're interested in health-care stocks like IPC The Hospitalist, you might want to expand your horizons to find maximum returns. Follow the money and meet a prime candidate for major returns in our new report, "Discover the Next Rule-Breaking Multibagger." Click here for instant access to this free report.
- Add IPC The Hospitalist to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.